FOSCAVIR Side Effects

7001714-X | C-reactive Protein Increased, Decreased Appetite, Hypokalaemia, Vomiting
on Sep 16, 2010 Female patient from JAPAN , 67 years of age, weighting 101.4 lb, was diagnosed with cytomegalovirus chorioretinitis, prophylaxis against gastrointestinal ulcer, haemorrhage prophylaxis, fungal infection (What is fungal infection?), pneumocystis jiroveci pneumonia and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, decreased appetite, hypokalaemia, vomiting. Foscavir dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), ADONA (View Adona Review and Adona Label ), ULCERLMIN (View Ulcerlmin Review and Ulcerlmin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ).

6979070-2 | C-reactive Protein Increased, Decreased Appetite, Hypokalaemia, Vomiting
Patient was taking Foscavir (View Usage). Patient had the following side effects: c-reactive protein increased, decreased appetite, hypokalaemia, vomiting on Sep 08, 2010 from JAPAN Additional patient health information: Female patient , weighting 101.4 lb, was diagnosed with cytomegalovirus chorioretinitis, prophylaxis against gastrointestinal ulcer, haemorrhage prophylaxis, fungal infection (What is fungal infection?), pneumocystis jiroveci pneumonia, osteoporosis prophylaxis, vitamin k deficiency and. Foscavir dosage: . During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), ADONA (View Adona Review and Adona Label ), ULCERLMIN (View Ulcerlmin Review and Ulcerlmin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), BACTRAMIN (View Bactramin Review and Bactramin Label ), ONEALFA (View Onealfa Review and Onealfa Label ), GLAKAY (View Glakay Review and Glakay Label ).

6976339-2 | Hypoglycaemic Seizure, Renal Impairment
Adverse event was reported on Sep 01, 2010 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus chorioretinitis and. Location: JAPAN , 40 years of age, After Foscavir was administered, patient had the following side effects: hypoglycaemic seizure, renal impairment.

6965587-3 | C-reactive Protein Increased, Decreased Appetite, Hypokalaemia, Nausea
on Aug 30, 2010 Female patient from JAPAN , 67 years of age, was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, decreased appetite, hypokalaemia, nausea (What is nausea?). Foscavir dosage: . During the same period patient was treated with THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ).


6910392-7 | Interstitial Lung Disease
on Aug 02, 2010 Female patient from JAPAN , 64 years of age, was treated with Foscavir (View Usage). Patient had the following side effects: interstitial lung disease. Foscavir dosage: .

6684895-7 | Grand Mal Convulsion, Status Epilepticus
Patient was taking Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: grand mal convulsion, status epilepticus on Apr 08, 2010 from FRANCE Additional patient health information: Female patient , 64 years of age, weighting 163.1 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Foscavir dosage: . During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ), TAHOR (View Tahor Review and Tahor Label ), CALCIUM (View Calcium Review and Calcium Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), HEPARIN (View Heparin Review and Heparin Label ).

6676323-2 | Central Nervous System Lymphoma, Grand Mal Convulsion, Status Epilepticus
Adverse event was reported on Apr 08, 2010 by a Female patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: FRANCE , 64 years of age, weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: central nervous system lymphoma, grand mal convulsion, status epilepticus. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ), TAHOR (View Tahor Review and Tahor Label ), CALCIUM (View Calcium Review and Calcium Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), HEPARIN (View Heparin Review and Heparin Label ).

6645732-X | Condition Aggravated, Hypocalcaemia
on Mar 15, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with cytomegalovirus colitis and was treated with Foscavir (View Usage). Patient had the following side effects: condition aggravated, hypocalcaemia. Foscavir dosage: .

6617974-0 | Grand Mal Convulsion, Status Epilepticus
on Mar 04, 2010 Female patient from FRANCE , 64 years of age, weighting 163.1 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: grand mal convulsion, status epilepticus. Foscavir dosage: . During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), INIPOMP (View Inipomp Review and Inipomp Label ), TAHOR (View Tahor Review and Tahor Label ), CALCIUM (View Calcium Review and Calcium Label ), DIFFU K (View Diffu-k Review and Diffu-k Label ), HEPARIN (View Heparin Review and Heparin Label ).

6543730-8 | Hypocalcaemia, Hypomagnesaemia, Paraesthesia, Renal Tubular Disorder
Patient was taking Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, hypomagnesaemia, paraesthesia, renal tubular disorder on Jan 11, 2010 from FRANCE Additional patient health information: Female patient , 62 years of age, . Foscavir dosage: . During the same period patient was treated with ADVAGRAF (1 Mg, 2.5 Capsules Daily) (View Advagraf Review and Advagraf Label ), CERTICAN (View Certican Review and Certican Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), KEPPRA (500 Mg In The Morning, 1000 Mg In The Evening) (View Keppra Review and Keppra Label ), SKENAN LP (View Skenan Lp Review and Skenan Lp Label ). Patient was hospitalized.

6441571-3 | Neutrophil Count Decreased
Adverse event was reported on Nov 04, 2009 by a Female patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus test positive and. Location: JAPAN , 31 years of age, Patient had the following side effects: neutrophil count decreased. During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), BAKTAR (View Baktar Review and Baktar Label ), DEPAKENE (View Depakene Review and Depakene Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DENOSINE (View Denosine Review and Denosine Label ).

6413471-6 | Hypocalcaemia, Nausea, Renal Disorder
on Oct 16, 2009 Female patient from JAPAN , 32 years of age, was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: hypocalcaemia, nausea (What is nausea?), renal disorder. Foscavir dosage: The Single Dose Was Adjusted Between 62.5ml And 150 Ml Two Times A Day. Patient was hospitalized.

6406103-4 | Bradycardia, Dizziness, Electrolyte Imbalance, Orthostatic Hypotension, Pancytopenia, Vomiting
on Oct 08, 2009 Male patient from JAPAN , 55 years of age, was diagnosed with cytomegalovirus viraemia and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dizziness (What is dizziness?), electrolyte imbalance, orthostatic hypotension, pancytopenia, vomiting. Foscavir dosage: . During the same period patient was treated with DENOSINE (View Denosine Review and Denosine Label ), ITRIZOLE (View Itrizole Review and Itrizole Label ), BAKTAR (View Baktar Review and Baktar Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PROGRAF (View Prograf Review and Prograf Label ). Patient was hospitalized.

6317717-4 | Renal Failure Acute
Patient was taking Foscavir (View Usage). Patient had the following side effects: renal failure acute on Aug 19, 2009 from FRANCE Additional patient health information: Female patient , weighting 152.1 lb, was diagnosed with septic shock, sedation and. Foscavir dosage: . During the same period patient was treated with NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ), AMIKLIN (View Amiklin Review and Amiklin Label ), INSULIN (View Insulin Review and Insulin Label ), BENZODIAZEPINE (View Benzodiazepine Review and Benzodiazepine Label ), MORPHINE (View Morphine Review and Morphine Label ), NIMBEX (View Nimbex Review and Nimbex Label ), TAZOCILLINE (4 G X 3) (View Tazocilline Review and Tazocilline Label ). Patient was hospitalized.

6209879-4 | Blood Bilirubin Increased, Blood Potassium Decreased, Renal Failure, Respiratory Failure
Adverse event was reported on May 29, 2009 by a Female patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), systemic mycosis, pyelonephritis fungal, neutropenia and. Location: JAPAN , weighting 43.43 lb, After Foscavir was administered, patient had the following side effects: blood bilirubin increased, blood potassium decreased, renal failure, respiratory failure. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ). Patient was hospitalized.

6206491-8 | Ascites, Blood Bilirubin Increased, Blood Potassium Decreased, Continuous Haemodiafiltration, Haemoglobin Decreased, Neuroblastoma Recurrent, Platelet Count Decreased, Pulmonary Oedema, Renal Failure
on May 25, 2009 Female patient from JAPAN , weighting 43.43 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), systemic mycosis, pyelonephritis fungal, neutropenia and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, blood bilirubin increased, blood potassium decreased, continuous haemodiafiltration, haemoglobin decreased, neuroblastoma recurrent, platelet count decreased, pulmonary oedema, renal failure. Foscavir dosage: . During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ).

6194909-9 | Balanitis, Penile Ulceration, Urethritis
on May 13, 2009 Male patient from SPAIN , 31 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Foscavir (View Usage). Patient had the following side effects: balanitis, penile ulceration, urethritis. Foscavir dosage: . During the same period patient was treated with CALCIUM SANDOZ (Fix Combination) (View Calcium-sandoz Review and Calcium-sandoz Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ), SEPTRIN FORTE (Fix Combination) (View Septrin Forte Review and Septrin Forte Label ). Patient was hospitalized.

6182939-2 | Pyramidal Tract Syndrome
Patient was taking Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: pyramidal tract syndrome on May 04, 2009 from FRANCE Additional patient health information: Male patient , 15 years of age, . Foscavir dosage: . During the same period patient was treated with CYMEVAN (View Cymevan Review and Cymevan Label ), FORTUM (View Fortum Review and Fortum Label ), TARGOCID (View Targocid Review and Targocid Label ). Patient was hospitalized.

6176561-1 | Chest Discomfort, Dyspnoea
Adverse event was reported on Apr 24, 2009 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: JAPAN , 43 years of age, Patient experienced the following unwanted or unexpected effects: chest discomfort, dyspnoea.

6168152-3 | Ileus Paralytic
on Apr 22, 2009 Male patient from JAPAN , child 10 years of age, was treated with Foscavir (View Usage). Patient had the following side effects: ileus paralytic. Foscavir dosage: .

6158619-6 | Blood Bilirubin Increased, Blood Potassium Decreased, Renal Failure, Respiratory Failure
on Apr 08, 2009 Female patient from JAPAN , weighting 43.43 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), systemic mycosis, pyelonephritis fungal, neutropenia and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: blood bilirubin increased, blood potassium decreased, renal failure, respiratory failure. Foscavir dosage: . During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ), NEUTROGIN (View Neutrogin Review and Neutrogin Label ).

6021929-7 | Blood Creatinine Increased, Renal Tubular Disorder, Retinal Detachment, Visual Acuity Reduced
Patient was taking Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal tubular disorder, retinal detachment, visual acuity reduced on Dec 18, 2008 from JAPAN Additional patient health information: Male patient , 41 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Foscavir dosage: 250 Ml Was Administered At Night On 15-jul..

5979418-1 | Diplopia, Paraesthesia
Adverse event was reported on Nov 26, 2008 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: FRANCE , 41 years of age, Patient had the following side effects: diplopia, paraesthesia. During the same period patient was treated with CYMEVAN (View Cymevan Review and Cymevan Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

5917464-4 | Bronchopulmonary Aspergillosis, Cytomegalovirus Chorioretinitis
on Oct 06, 2008 Female patient from JAPAN , 57 years of age, was diagnosed with cytomegalovirus chorioretinitis, antibiotic prophylaxis, pneumonia (What is pneumonia?), renal disorder and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: bronchopulmonary aspergillosis, cytomegalovirus chorioretinitis. Foscavir dosage: . During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), COTRIM (View Cotrim Review and Cotrim Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5916861-0 | C-reactive Protein Increased, Pancytopenia
on Oct 09, 2008 Male patient from JAPAN , 49 years of age, was diagnosed with encephalitis cytomegalovirus, hiv infection (What is hiv infection?), oral candidiasis and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, pancytopenia. Foscavir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), EPZICOM (View Epzicom Review and Epzicom Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ).

5868883-6 | Stevens-johnson Syndrome
Patient was taking Foscavir (View Usage). Patient had the following side effects: stevens-johnson syndrome on Aug 26, 2008 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), oedema, bacterial infection (What is bacterial infection?), fungal infection (What is fungal infection?) and. Foscavir dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), FUNGUARD (View Funguard Review and Funguard Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5868871-X | Cytomegalovirus Antigen Positive, Glaucoma, Hypokalaemia, Hyponatraemia, Renal Impairment, Uveitis
Adverse event was reported on Aug 26, 2008 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus enterocolitis, cytomegalovirus antigen positive, cytomegalovirus viraemia and. Location: UNITED STATES , 58 years of age, After Foscavir was administered, patient had the following side effects: cytomegalovirus antigen positive, glaucoma (What is glaucoma?), hypokalaemia, hyponatraemia, renal impairment, uveitis. Patient was hospitalized.

5844972-7 | Erythema
on Aug 06, 2008 Male patient from JAPAN , 59 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), oedema, bacterial infection (What is bacterial infection?), fungal infection (What is fungal infection?) and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: erythema. Foscavir dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PANSPORIN (View Pansporin Review and Pansporin Label ), FUNGUARD (View Funguard Review and Funguard Label ), COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5842328-4 | Acute Respiratory Failure, Bone Marrow Failure, C-reactive Protein Increased, Cerebral Toxoplasmosis, Disseminated Intravascular Coagulation, Eating Disorder, Encephalitis, Hypoalbuminaemia, Loss Of Consciousness
on Feb 04, 2008 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with infection prophylaxis, encephalitis cytomegalovirus, hiv infection (What is hiv infection?) and was treated with Foscavir (View Usage). Patient had the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder (What is eating disorder?), encephalitis (What is encephalitis?), hypoalbuminaemia, loss of consciousness. Foscavir dosage: . Patient was hospitalized.

5840608-X | Acute Respiratory Failure, C-reactive Protein Increased, Cerebral Toxoplasmosis, Disseminated Intravascular Coagulation, Eating Disorder, Encephalitis, Hypoalbuminaemia, Loss Of Consciousness, Pancytopenia
Patient was taking Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: acute respiratory failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder (What is eating disorder?), encephalitis (What is encephalitis?), hypoalbuminaemia, loss of consciousness, pancytopenia on Aug 07, 2008 from JAPAN Additional patient health information: Male patient , 49 years of age, was diagnosed with encephalitis cytomegalovirus, hiv infection (What is hiv infection?), oral candidiasis and. Foscavir dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), EPZICOM (View Epzicom Review and Epzicom Label ), FUNGIZONE (View Fungizone Review and Fungizone Label ). Patient was hospitalized.

5835222-6 | Bronchopulmonary Aspergillosis, Cytomegalovirus Chorioretinitis, Renal Impairment
Adverse event was reported on Jul 28, 2008 by a Female patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus chorioretinitis, antibiotic prophylaxis, pneumonia (What is pneumonia?), renal disorder and. Location: JAPAN , 57 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, cytomegalovirus chorioretinitis, renal impairment. During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), COTRIM (View Cotrim Review and Cotrim Label ), NORVASC (View Norvasc Review and Norvasc Label ).

5834109-2 | Cytomegalovirus Antigen Positive, Glaucoma, Hypokalaemia, Hyponatraemia, Renal Impairment, Uveitis
on Jul 28, 2008 Male patient from UNITED STATES , 58 years of age, was diagnosed with cytomegalovirus enterocolitis, cytomegalovirus antigen positive, hiv infection (What is hiv infection?) and was treated with Foscavir (View Usage). Patient had the following side effects: cytomegalovirus antigen positive, glaucoma (What is glaucoma?), hypokalaemia, hyponatraemia, renal impairment, uveitis. Foscavir dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ). Patient was hospitalized.

5834104-3 | Diplopia, Paraesthesia
on Jul 30, 2008 Male patient from FRANCE , 41 years of age, was diagnosed with infection (What is infection?) and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: diplopia, paraesthesia. Foscavir dosage: . During the same period patient was treated with CYMEVAN (View Cymevan Review and Cymevan Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PRODAFALGAN (View Prodafalgan Review and Prodafalgan Label ), SOLUPRED (View Solupred Review and Solupred Label ). Patient was hospitalized.

5833670-1 | Aids Encephalopathy
Patient was taking Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: aids encephalopathy on Jul 28, 2008 from JAPAN Additional patient health information: Male patient , 35 years of age, was diagnosed with cytomegalovirus chorioretinitis, pneumocystis jiroveci pneumonia, pneumonia fungal and. Foscavir dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), COTRIM (View Cotrim Review and Cotrim Label ), FUNGUARD (View Funguard Review and Funguard Label ).

5828524-0 | Blood Calcium Increased, Polyneuropathy
Adverse event was reported on Jul 21, 2008 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: FRANCE , 40 years of age, Patient had the following side effects: blood calcium increased, polyneuropathy. During the same period patient was treated with CYMEVAN (View Cymevan Review and Cymevan Label ), AVLOCARDYL (View Avlocardyl Review and Avlocardyl Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SOLUPRED (View Solupred Review and Solupred Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

5819341-6 | Genital Ulceration, Mouth Ulceration, Renal Tubular Disorder
on Jul 08, 2008 Female patient from FRANCE , 65 years of age, was diagnosed with necrotising retinitis and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: genital ulceration, mouth ulceration, renal tubular disorder. Foscavir dosage: . Patient was hospitalized.

5777669-2 | Cytomegalovirus Antigen Positive, Glaucoma, Hypokalaemia, Hyponatraemia, Renal Impairment, Uveitis
on Jun 10, 2008 Male patient from UNITED STATES , 58 years of age, was diagnosed with cytomegalovirus enterocolitis, cytomegalovirus antigen positive, hiv infection (What is hiv infection?) and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus antigen positive, glaucoma (What is glaucoma?), hypokalaemia, hyponatraemia, renal impairment, uveitis. Foscavir dosage: . During the same period patient was treated with STOCRIN (View Stocrin Review and Stocrin Label ). Patient was hospitalized.

5615448-7 | Acute Respiratory Failure, Bone Marrow Failure, C-reactive Protein Increased, Cerebral Toxoplasmosis, Disseminated Intravascular Coagulation, Eating Disorder, Encephalitis, Hypoalbuminaemia, Loss Of Consciousness
Patient was taking Foscavir (View Usage). Patient had the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder (What is eating disorder?), encephalitis (What is encephalitis?), hypoalbuminaemia, loss of consciousness on Feb 04, 2008 from JAPAN Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with infection prophylaxis, encephalitis cytomegalovirus, hiv infection (What is hiv infection?) and. Foscavir dosage: . Patient was hospitalized.

5604687-7 | Acute Respiratory Failure, Bone Marrow Failure, C-reactive Protein Increased, Cerebral Toxoplasmosis, Disseminated Intravascular Coagulation, Eating Disorder, Encephalitis, Hypoalbuminaemia, Loss Of Consciousness
Adverse event was reported on Jan 21, 2008 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with infection prophylaxis, encephalitis cytomegalovirus, hiv infection (What is hiv infection?) and. Location: JAPAN , weighting 127.9 lb, After Foscavir was administered, patient had the following side effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder (What is eating disorder?), encephalitis (What is encephalitis?), hypoalbuminaemia, loss of consciousness. Patient was hospitalized.

5600411-2 | Acute Respiratory Failure, Bone Marrow Failure, C-reactive Protein Increased, Cerebral Toxoplasmosis, Disseminated Intravascular Coagulation, Eating Disorder, Encephalitis, Hypoalbuminaemia, Loss Of Consciousness
on Nov 28, 2007 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with infection prophylaxis, encephalitis cytomegalovirus, hiv infection (What is hiv infection?) and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, bone marrow failure, c-reactive protein increased, cerebral toxoplasmosis, disseminated intravascular coagulation, eating disorder (What is eating disorder?), encephalitis (What is encephalitis?), hypoalbuminaemia, loss of consciousness. Foscavir dosage: . Patient was hospitalized.

5599822-3 | Bone Marrow Failure, C-reactive Protein Increased, Pancytopenia
on Nov 13, 2007 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with hiv infection (What is hiv infection?), encephalitis cytomegalovirus and was treated with Foscavir (View Usage). Patient had the following side effects: bone marrow failure, c-reactive protein increased, pancytopenia. Foscavir dosage: . During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), EPZICOM (View Epzicom Review and Epzicom Label ).

5579081-8 | Blood Pressure Increased, Cerebral Haemorrhage
Patient was taking Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: blood pressure increased, cerebral haemorrhage on Dec 27, 2007 from ITALY Additional patient health information: Male patient , child 12 years of age, weighting 72.75 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Foscavir dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DESAMETASONE (View Desametasone Review and Desametasone Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), MEPRAL (View Mepral Review and Mepral Label ).

5546950-4 | Blood Pressure Increased, Cerebral Haemorrhage
Adverse event was reported on Dec 06, 2007 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: ITALY , child 12 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, cerebral haemorrhage. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DESAMETASONE (View Desametasone Review and Desametasone Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), MEPRAL (View Mepral Review and Mepral Label ), PROZAC (View Prozac Review and Prozac Label ), NUREFLEX (View Nureflex Review and Nureflex Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

5542485-3 | Cerebral Haemorrhage
on Dec 06, 2007 Male patient from ITALY , child 12 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Foscavir (View Usage). Patient had the following side effects: cerebral haemorrhage. Foscavir dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DESAMETASONE (View Desametasone Review and Desametasone Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), MEPRAL (View Mepral Review and Mepral Label ), PROZAC (View Prozac Review and Prozac Label ), NUREFLEX (View Nureflex Review and Nureflex Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

5527783-1 | Bone Marrow Failure, C-reactive Protein Increased, Pancytopenia
on Nov 13, 2007 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with hiv infection (What is hiv infection?), encephalitis cytomegalovirus and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: bone marrow failure, c-reactive protein increased, pancytopenia. Foscavir dosage: . During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), EPZICOM (View Epzicom Review and Epzicom Label ).

5525895-X | Blood Pressure Increased, Convulsion, Encephalopathy, Headache, Loss Of Consciousness, Paraesthesia Oral, Vision Blurred
Patient was taking Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, convulsion, encephalopathy, headache (What is headache?), loss of consciousness, paraesthesia oral, vision blurred on Nov 19, 2007 from ITALY Additional patient health information: Male patient , child 12 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Foscavir dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DESAMETASONE (View Desametasone Review and Desametasone Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), MEPRAL (View Mepral Review and Mepral Label ), PROZAC (View Prozac Review and Prozac Label ), NUREFLEX (View Nureflex Review and Nureflex Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

5523623-5 | Blood Pressure Increased, Convulsion, Encephalopathy, Headache, Loss Of Consciousness, Paraesthesia Oral, Vision Blurred
Adverse event was reported on Nov 19, 2007 by a Male patient taking Foscavir (View Usage) (Dosage: ) was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: ITALY , child 12 years of age, Patient had the following side effects: blood pressure increased, convulsion, encephalopathy, headache (What is headache?), loss of consciousness, paraesthesia oral, vision blurred. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), DESAMETASONE (View Desametasone Review and Desametasone Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), CIPROXIN (View Ciproxin Review and Ciproxin Label ), MEPRAL (View Mepral Review and Mepral Label ), PROZAC (View Prozac Review and Prozac Label ), NUREFLEX (View Nureflex Review and Nureflex Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

5522316-8 | Amnesia, Confusional State, Fatigue, Ill-defined Disorder, Mental Status Changes
on Nov 13, 2007 Male patient from UNITED STATES , 16 years of age, weighting 256.0 lb, was diagnosed with cytomegalovirus test positive and was treated with Foscavir (View Usage). After Foscavir was administered, patient had the following side effects: amnesia, confusional state, fatigue, ill-defined disorder, mental status changes. Foscavir dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5521154-X | Blood Pressure Increased, Convulsion, Headache, Loss Of Consciousness, Paraesthesia Oral, Vision Blurred
on Nov 14, 2007 Male patient from ITALY , child 12 years of age, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?) and was treated with Foscavir (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, convulsion, headache (What is headache?), loss of consciousness, paraesthesia oral, vision blurred. Foscavir dosage: .

5516893-0 | Genital Discomfort, Genital Ulceration
Patient was taking Foscavir (View Usage). Patient had the following side effects: genital discomfort, genital ulceration on Nov 05, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 41 years of age, weighting 167.6 lb, was diagnosed with cytomegalovirus infection (What is cytomegalovirus infection?), immunosuppression, hypercholesterolaemia, depression (What is depression?) and. Foscavir dosage: 84 Mg/kg/day Given Twice Daily. During the same period patient was treated with TACROLIMUS (Daily Dosage, Variable) (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).